Abstract
Tolerogenic antigen presenting cells (APC), primarily dendritic cells (DC), are essential to the induction and maintenance of immunologic tolerance in clinical transplantation. They induce the differentiation of CD8+ T suppressor (Ts) and CD4+ T regulatory (Treg) or anergic cells, which prevent transplant rejection maintaining a state of quiescence. Tolerogenic APC express high levels of inhibitory receptors such as Immunoglobulin-like transcript (ILT)3 and 4 which inhibit the effector function of T cells that recognize HLA-peptide complexes on APC. Here, we describe the methods for detection of tolerogenic APC induced by allospecific Ts/Treg cells.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Vlad G, Cortesini R, Suciu-Foca N (2005) License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC. J Immunol 174:5907–5914
Penna G, Giarratana N, Amuchastegui S et al (2005) Manipulating dendritic cells to induce regulatory T cells. Microbes Infect 7:1033–1039
Vlad G, Chang CC, Colovai AI et al (2009) Immunoglobulin-like transcript 3: a crucial regulator of dendritic cell function. Hum Immunol 70:340–344
Lanzavecchia A (1998) Immunology. Licence to kill. Nature 393:413–414
Ridge JP, Di Rosa F, Matzinger P (1998) A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393:474–478
Bennett SR, Carbone FR, Karamalis F et al (1998) Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478–480
Schoenberger SP, Toes RE, van der Voort EI et al (1998) T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480–483
Heath WR, Carbone FR (2001) Cross-presentation in viral immunity and self-tolerance. Nat Rev Immunol 1:126–134
Chang CC, Liu Z, Vlad G et al (2009) Ig-like transcript 3 regulates expression of proinflammatory cytokines and migration of activated T cells. J Immunol 182:5208–5216
Liu Z, Tugulea S, Cortesini R et al (1998) Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28− T cells. Int Immunol 10:775–783
Chang CC, Ciubotariu R, Manavalan JS et al (2002) Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 3:237–243
Manavalan JS, Rossi PC, Vlad G et al (2003) High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl Immunol 11:245–258
Adorini L, Giarratana N, Penna G (2004) Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin Immunol 16:127–134
Adorini L, Penna G (2009) Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists. Hum Immunol 70:345–352
Ciubotariu R, Vasilescu R, Ho E et al (2001) Detection of T suppressor cells in patients with organ allografts. Hum Immunol 62:15–20
Manavalan JS, Kim-Schulze S, Scotto L et al (2004) Alloantigen specific CD8+CD28− FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol 16:1055–1068
Liu J, Liu Z, Witkowski P et al (2004) Rat CD8+ FOXP3+ T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejection. Transpl Immunol 13:239–247
Liu Z, Colovai AI, Tugulea S et al (1996) Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest 98:1150–1157
Ciubotariu R, Liu Z, Colovai AI et al (1998) Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest 101:398–405
Liu Z, Tugulea S, Cortesini R et al (1999) Inhibition of CD40 signaling pathway in antigen presenting cells by T suppressor cells. Hum Immunol 60:568–574
Boks MA, Zwaginga JJ, van Ham SM et al (2010) An optimized CFSE-based T-cell suppression assay to evaluate the suppressive capacity of regulatory T-cells induced by human tolerogenic dendritic cells. Scand J Immunol 72:158–168
Vieira PL, Kalinski P, Wierenga EA et al (1998) Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. J Immunol 161:5245–5251
Matasic R, Dietz AB, Vuk-Pavlovic S (1999) Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells. J Leukoc Biol 66:909–914
Piemonti L, Monti P, Allavena P et al (1999) Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol 162:6473–6481
Woltman AM, de Fijter JW, Kamerling SW et al (2000) The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur J Immunol 30:1807–1812
Mehling A, Grabbe S, Voskort M et al (2000) Mycophenolate mofetil impairs the maturation and function of murine dendritic cells. J Immunol 165:2374–2381
Colic M, Stojic-Vukanic Z, Pavlovic B et al (2003) Mycophenolate mofetil inhibits differentiation, maturation and allostimulatory function of human monocyte-derived dendritic cells. Clin Exp Immunol 134:63–69
Woltman AM, de Fijter JW, Kamerling SW et al (2001) Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages. Blood 98:174–180
Hackstein H, Taner T, Zahorchak AF et al (2003) Rapamycin inhibits IL-4–induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood 101:4457–4463
Matasic R, Dietz AB, Vuk-Pavlovic S (2000) Cyclooxygenase-independent inhibition of dendritic cell maturation by aspirin. Immunology 101:53–60
Hackstein H, Morelli AE, Larregina AT et al (2001) Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells. J Immunol 166:7053–7062
Millard AL, Mertes PM, Ittelet D et al (2002) Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophages. Clin Exp Immunol 130:245–255
Verhasselt V, Vanden Berghe W, Vanderheyde N et al (1999) N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibition. J Immunol 162:2569–2574
Cella M, Jarrossay D, Facchetti F et al (1999) Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 5:919–923
Penna G, Sozzani S, Adorini L (2001) Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J Immunol 167:1862–1866
Gilliet M, Liu YJ (2002) Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 195:695–704
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Vlad, G., Suciu-Foca, N. (2013). Tolerogenic Dendritic Cells and Induction of T Suppressor Cells in Transplant Recipients. In: Zachary, A., Leffell, M. (eds) Transplantation Immunology. Methods in Molecular Biology, vol 1034. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-493-7_23
Download citation
DOI: https://doi.org/10.1007/978-1-62703-493-7_23
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-492-0
Online ISBN: 978-1-62703-493-7
eBook Packages: Springer Protocols